港股市場個股詳情

08049 吉林長龍藥業

添加自選

1.590
-0.050-3.05%

未開盤 05/02 16:08 (北京)

8.91億總市值5.45市盈率TTM

吉林長龍藥業股票討論區

登錄發表評論

Moomoo AI

2023/12/30 06:47

Despite strong EPS growth, the company's P/E is low due to investor expectations that recent limited growth rates will persist. Without an improvement in recent medium-term conditions, the low P/E is expected to limit the growth potential of the stock.

Improved Earnings Required Before Jilin Province Huinan Changlong Bio-pharmacy Company Limited (HKG:8049) Stock's 25% Jump Looks Justified

暫無評論

分析

分析師評級

暫無數據

目標價預測

暫無數據

熱議

港股

綜合熱度